Cannabis Stocks Rallied After Rescheduling News, Investment Management Firm Co-Founder Discusses Impact And Next Steps
Portfolio Pulse from Patricio Liddle
Cannabis stocks surged following the U.S. Department of Justice's proposal to reclassify cannabis from a Schedule I to a Schedule III drug. Canopy Growth (NASDAQ:CGC) led the surge, with Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) also seeing gains. Cannabis ETFs like AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) and Amplify Alternative Harvest ETF (NYSE:MJ) experienced increased trading but later pulled back. Emily Paxhia of Poseidon Investment Management discussed the broader implications and challenges ahead.
May 20, 2024 | 3:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aurora Cannabis saw gains following the DOJ's rescheduling news but has since pulled back.
Aurora Cannabis initially saw gains but has since pulled back, indicating a neutral short-term impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Amplify Alternative Harvest ETF saw a 2.5% increase following the rescheduling news but later traded 2.04% lower.
The ETF saw an initial increase but later pulled back, indicating a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
AdvisorShares Pure US Cannabis ETF saw a 2.5% increase following the rescheduling news but later traded 0.82% lower.
The ETF saw an initial increase but later pulled back, indicating a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Tilray Brands experienced robust gains following the DOJ's rescheduling news but has since pulled back.
While Tilray initially benefited from the news, the stock has since pulled back, indicating a more neutral short-term impact.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Canopy Growth saw a significant stock price increase following the DOJ's proposal to reclassify cannabis. The stock has climbed 115% year-to-date.
The DOJ's proposal is a major regulatory change that directly benefits Canopy Growth, leading to a significant stock price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100